Your browser doesn't support javascript.
loading
Natural history of Waldenström macroglobulinemia following acquired resistance to ibrutinib monotherapy.
Gustine, Joshua N; Sarosiek, Shayna; Flynn, Catherine A; Meid, Kirsten; Leventoff, Carly; White, Timothy; Guerrera, Maria Luisa; Xu, Lian; Kofides, Amanda; Tsakmaklis, Nicholas; Munshi, Manit; Demos, Maria; Patterson, Christopher J; Liu, Xia; Yang, Guang; Hunter, Zachary R; Branagan, Andrew R; Treon, Steven P; Castillo, Jorge J.
  • Gustine JN; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA; Boston University School of Medicine.
  • Sarosiek S; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston MA.
  • Flynn CA; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Meid K; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Leventoff C; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • White T; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Guerrera ML; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Xu L; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Kofides A; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Tsakmaklis N; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Munshi M; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Demos M; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Patterson CJ; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Liu X; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Yang G; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston MA.
  • Hunter ZR; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston MA.
  • Branagan AR; Department of Medicine, Harvard Medical School, Boston MA, USA; Division of Medical Oncology, Massachusetts General Hospital, Boston MA.
  • Treon SP; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston MA.
  • Castillo JJ; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston MA. jorgej_castillo@dfci.harvard.edu.
Haematologica ; 107(5): 1163-1171, 2022 05 01.
Article en En | MEDLINE | ID: mdl-34162182
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Macroglobulinemia de Waldenström Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Macroglobulinemia de Waldenström Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article